VENOZEL

This brand name is authorized in Poland

Active ingredients

The drug VENOZEL contains a combination of these active pharmaceutical ingredients (APIs):

1 Diclofenac
UNII QTG126297Q - DICLOFENAC SODIUM

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

Read about Diclofenac
2 Tribenoside
UNII Z7N0Y673NU - TRIBENOSIDE
Read about Tribenoside
3 Escin
UNII RUU8G67GQM - ESCIN
Read about Escin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C05CX01 Tribenoside C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CX Other capillary stabilizing agents
Discover more medicines within C05CX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100114261

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈